» Authors » BaoPing Chen

BaoPing Chen

Explore the profile of BaoPing Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 268
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Wang Y, Wang M, Chen B, Shi J
Eur J Pharmacol . 2017 Oct; 815:376-380. PMID: 28970015
Scoparone, a major constituent of Artemisia capillaries, has a variety of biological properties including anticoagulant, hepatoprotective, anti-tumor, anti-fibrosis, anti-inflammatory, antioxidant, and antidiabetic activities. However, the renoprotective effect of scoparone under...
22.
Zhang J, Yang S, Chen F, Li H, Chen B
Cell Biosci . 2017 Aug; 7:44. PMID: 28852469
Background: Ginkgetin aglycone (GA), a novel extract (GBE) by acid hydrolysis and recrystallization, is characterized by higher liposolubility and antioxidation than classical GBEs. There is no study depicting the functional...
23.
Wang Y, Wang M, Chen B, Shi J
Open Med (Wars) . 2017 Mar; 10(1):468-472. PMID: 28352738
The aim of the study was to find the correlation between CRP and chemerin in development of DN. We choose 90 type-2 diabetic patients between February 2010 and February 2013,...
24.
Wang Y, Li H, Chen B
Saudi Pharm J . 2016 Jun; 24(3):337-40. PMID: 27275125
Objective: Pathogen distribution characteristics of nephrology patients with urinary tract infections are studied, and drug resistance of nephrology and urinary tract infection disease are analyzed, so as to provide sufficient...
25.
Shi J, Liu C, Zhang A, Cui N, Wang B, Chen B, et al.
Zhonghua Yi Xue Za Zhi . 2014 Oct; 94(26):2004-7. PMID: 25312658
Objective: To explore the expression levels and roles of Krüpple-like factor 5 (KLF5) in tumor necrosis factor α (TNFα)-induced SK-BR-3 breast cancer cells. Methods: SK-BR-3 breast cancer cells were stimulated...
26.
Wen M, Xu W, Ren L, Gao F, Cui N, Wen J, et al.
Chin Med J (Engl) . 2014 Apr; 127(7):1328-33. PMID: 24709189
Background: Adoptive cell transfer (ACT) immunotherapy has been used clinically for years to treat malignancies. Improving the killing efficiency of effector cells, such as tumor-specific cytotoxic T lymphocytes (CTLs), is...